US Stock MarketDetailed Quotes

CALA Calithera Biosciences

Watchlist

0.007000
0.0000000.00%

15min DelayClose Oct 31 16:00 ET

34.11KMarket Cap0.00P/E (TTM)

Calithera Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

34.23%-43.61M

66.38%-8.6M

-1.72%-7.74M

-1.29%-11.26M

27.23%-16.01M

21.36%-66.3M

-11.18%-25.57M

53.35%-7.61M

38.20%-11.12M

18.56%-22M

Net income from continuing operations

65.55%-39.65M

89.98%-6.94M

12.26%-9.8M

36.57%-9.08M

32.16%-13.84M

-27.68%-115.09M

-206.70%-69.21M

50.86%-11.17M

29.82%-14.31M

16.57%-20.4M

Operating gains losses

---1.95M

---169K

--453K

----

Depreciation and amortization

-8.93%255K

0.00%65K

-10.14%62K

-12.33%64K

-23.08%280K

-20.73%65K

-19.77%69K

-19.78%73K

-30.48%73K

Other non cash items

-97.29%1.13M

-99.29%292K

9.58%286K

9.41%279K

2,581.82%273K

2,665.41%41.65M

10,449.23%41.14M

-31.68%261K

-31.45%255K

-103.04%-11K

Change In working capital

-118.09%-7.43M

-3,456.63%-2.79M

-50.61%326K

-681.74%-1.27M

15.46%-3.69M

14.08%-3.41M

102.95%83K

-82.85%660K

477.59%219K

11.67%-4.37M

-Change in receivables

--0

-87.50%127K

-124.76%-127K

245.51%1.54M

101.12%12K

--0

1,816.98%1.02M

203.85%513K

-Change in prepaid assets

672.92%742K

-532.56%-544K

788.14%406K

19.30%1.03M

76.41%-146K

265.52%96K

64.46%-86K

78.39%-59K

280.53%860K

-367.97%-619K

-Change in payables and accrued expense

-75.69%-6.79M

-495.18%-1.89M

-73.04%265K

-36.03%-2.09M

18.62%-3.09M

-134.65%-3.87M

134.07%477K

-72.95%983K

-1,400.85%-1.54M

5.20%-3.79M

-Change in other current assets

--0

----

--0

----

-Change in other current liabilities

-16.94%-1.37M

-11.56%-357K

-11.29%-345K

-346.05%-339K

29.00%-333K

20.50%-1.18M

26.61%-320K

-36.56%-310K

81.55%-76K

-16.38%-469K

Cash from discontinued investing activities

Operating cash flow

34.23%-43.61M

66.38%-8.6M

-1.72%-7.74M

-1.29%-11.26M

27.23%-16.01M

21.36%-66.3M

-11.18%-25.57M

53.35%-7.61M

38.20%-11.12M

18.56%-22M

Investing cash flow

Cash flow from continuing investing activities

-101.69%-133K

41.03%-23K

-107.33%-110K

-91.17%7.85M

-100.43%-39K

-100.49%-108K

-97.44%1.5M

1,158.63%6.5M

Net PPE purchase and sale

9.52%-133K

41.03%-23K

--0

----

-140.98%-147K

-8.33%-39K

-800.00%-108K

----

Net investment purchase and sale

--0

-91.01%8M

--0

-97.44%1.5M

1,181.53%6.5M

Cash from discontinued investing activities

Investing cash flow

-101.69%-133K

41.03%-23K

--0

-107.33%-110K

--0

-91.17%7.85M

-100.43%-39K

-100.49%-108K

-97.44%1.5M

1,158.63%6.5M

Financing cash flow

Cash flow from continuing financing activities

-9.50%9.66M

-99.39%4K

1,400.00%15K

1,689.26%8.5M

-88.08%1.14M

-74.64%10.67M

31.00%655K

-50.00%1K

-98.60%475K

24.52%9.54M

Net common stock issuance

-9.61%9.64M

--0

--15K

2,304.25%8.49M

-88.08%1.14M

-73.90%10.66M

--776K

--0

-98.95%353K

28.90%9.54M

Proceeds from stock option exercised by employees

-90.96%16K

-92.31%4K

--0

-90.16%12K

--0

-85.25%177K

-89.60%52K

--1K

-72.15%122K

-99.24%2K

Net other financing activities

----

---173K

----

Cash from discontinued financing activities

Financing cash flow

-9.50%9.66M

-99.39%4K

1,400.00%15K

1,689.26%8.5M

-88.08%1.14M

-74.64%10.67M

31.00%655K

-50.00%1K

-98.60%475K

24.52%9.54M

Net cash flow

Beginning cash position

-44.41%59.81M

-59.49%34.34M

-54.52%42.06M

-55.78%44.93M

-44.41%59.81M

76.73%107.59M

-29.96%84.76M

-19.82%92.48M

148.42%101.62M

76.73%107.59M

Current changes in cash

28.66%-34.09M

65.47%-8.62M

-0.12%-7.72M

68.57%-2.88M

-149.34%-14.87M

-202.29%-47.78M

-85.74%-24.96M

-235.61%-7.71M

-112.29%-9.15M

70.13%-5.97M

End cash Position

-56.99%25.72M

-59.49%34.34M

-54.52%42.06M

-55.78%44.93M

-44.41%59.81M

-29.96%84.76M

-19.82%92.48M

148.42%101.62M

Free cash flow

34.17%-43.74M

66.34%-8.62M

-0.30%-7.74M

-2.27%-11.37M

27.23%-16.01M

21.25%-66.45M

-11.17%-25.61M

52.72%-7.71M

38.20%-11.12M

18.60%-22M

Currency Unit

USD

Accounting Standards

US-GAAP

	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	34.23%-43.61M	66.38%-8.6M	-1.72%-7.74M	-1.29%-11.26M	27.23%-16.01M	21.36%-66.3M	-11.18%-25.57M	53.35%-7.61M	38.20%-11.12M	18.56%-22M
Net income from continuing operations	65.55%-39.65M	89.98%-6.94M	12.26%-9.8M	36.57%-9.08M	32.16%-13.84M	-27.68%-115.09M	-206.70%-69.21M	50.86%-11.17M	29.82%-14.31M	16.57%-20.4M
Operating gains losses	---1.95M	---169K	--453K	----	----	----	----	----	----	----
Depreciation and amortization	-8.93%255K	0.00%65K	-10.14%62K	-12.33%64K	-12.33%64K	-23.08%280K	-20.73%65K	-19.77%69K	-19.78%73K	-30.48%73K
Other non cash items	-97.29%1.13M	-99.29%292K	9.58%286K	9.41%279K	2,581.82%273K	2,665.41%41.65M	10,449.23%41.14M	-31.68%261K	-31.45%255K	-103.04%-11K
Change In working capital	-118.09%-7.43M	-3,456.63%-2.79M	-50.61%326K	-681.74%-1.27M	15.46%-3.69M	14.08%-3.41M	102.95%83K	-82.85%660K	477.59%219K	11.67%-4.37M
-Change in receivables	--0	--0	--0	-87.50%127K	-124.76%-127K	245.51%1.54M	101.12%12K	--0	1,816.98%1.02M	203.85%513K
-Change in prepaid assets	672.92%742K	-532.56%-544K	788.14%406K	19.30%1.03M	76.41%-146K	265.52%96K	64.46%-86K	78.39%-59K	280.53%860K	-367.97%-619K
-Change in payables and accrued expense	-75.69%-6.79M	-495.18%-1.89M	-73.04%265K	-36.03%-2.09M	18.62%-3.09M	-134.65%-3.87M	134.07%477K	-72.95%983K	-1,400.85%-1.54M	5.20%-3.79M
-Change in other current assets	--0	----	----	----	----	--0	----	----	----	----
-Change in other current liabilities	-16.94%-1.37M	-11.56%-357K	-11.29%-345K	-346.05%-339K	29.00%-333K	20.50%-1.18M	26.61%-320K	-36.56%-310K	81.55%-76K	-16.38%-469K
Cash from discontinued investing activities
Operating cash flow	34.23%-43.61M	66.38%-8.6M	-1.72%-7.74M	-1.29%-11.26M	27.23%-16.01M	21.36%-66.3M	-11.18%-25.57M	53.35%-7.61M	38.20%-11.12M	18.56%-22M
Investing cash flow
Cash flow from continuing investing activities	-101.69%-133K	41.03%-23K	0	-107.33%-110K	0	-91.17%7.85M	-100.43%-39K	-100.49%-108K	-97.44%1.5M	1,158.63%6.5M
Net PPE purchase and sale	9.52%-133K	41.03%-23K	--0	----	----	-140.98%-147K	-8.33%-39K	-800.00%-108K	----	----
Net investment purchase and sale	--0	--0	--0	--0	--0	-91.01%8M	--0	--0	-97.44%1.5M	1,181.53%6.5M
Cash from discontinued investing activities
Investing cash flow	-101.69%-133K	41.03%-23K	--0	-107.33%-110K	--0	-91.17%7.85M	-100.43%-39K	-100.49%-108K	-97.44%1.5M	1,158.63%6.5M
Financing cash flow
Cash flow from continuing financing activities	-9.50%9.66M	-99.39%4K	1,400.00%15K	1,689.26%8.5M	-88.08%1.14M	-74.64%10.67M	31.00%655K	-50.00%1K	-98.60%475K	24.52%9.54M
Net common stock issuance	-9.61%9.64M	--0	--15K	2,304.25%8.49M	-88.08%1.14M	-73.90%10.66M	--776K	--0	-98.95%353K	28.90%9.54M
Proceeds from stock option exercised by employees	-90.96%16K	-92.31%4K	--0	-90.16%12K	--0	-85.25%177K	-89.60%52K	--1K	-72.15%122K	-99.24%2K
Net other financing activities	----	----	----	----	----	---173K	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-9.50%9.66M	-99.39%4K	1,400.00%15K	1,689.26%8.5M	-88.08%1.14M	-74.64%10.67M	31.00%655K	-50.00%1K	-98.60%475K	24.52%9.54M
Net cash flow
Beginning cash position	-44.41%59.81M	-59.49%34.34M	-54.52%42.06M	-55.78%44.93M	-44.41%59.81M	76.73%107.59M	-29.96%84.76M	-19.82%92.48M	148.42%101.62M	76.73%107.59M
Current changes in cash	28.66%-34.09M	65.47%-8.62M	-0.12%-7.72M	68.57%-2.88M	-149.34%-14.87M	-202.29%-47.78M	-85.74%-24.96M	-235.61%-7.71M	-112.29%-9.15M	70.13%-5.97M
End cash Position	-56.99%25.72M	-56.99%25.72M	-59.49%34.34M	-54.52%42.06M	-55.78%44.93M	-44.41%59.81M	-44.41%59.81M	-29.96%84.76M	-19.82%92.48M	148.42%101.62M
Free cash flow	34.17%-43.74M	66.34%-8.62M	-0.30%-7.74M	-2.27%-11.37M	27.23%-16.01M	21.25%-66.45M	-11.17%-25.61M	52.72%-7.71M	38.20%-11.12M	18.60%-22M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data